{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-357968","form_type":"8-K","ticker":"BMRN","cik":"0001048477","company_name":"BIOMARIN PHARMACEUTICAL INC","filed_at":"2021-12-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.263005+00:00","generated_at":"2026-06-28T00:45:51.260529+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"BioMarin appoints Mark J. Alles to Board of Directors, effective Jan 1, 2022","bullets":["Board size increased from ten to eleven members; Alles appointed to Board and Audit Committee.","Appointment effective January 1, 2022; conditions satisfied December 10, 2021.","Alles to receive standard independent director compensation and pro rata RSU grant ($400,000 annual value).","No arrangement or understanding with any person for the appointment; no related party transactions."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-357968","json":"https://secwatch.observer/filing/0001193125-21-357968.json","markdown":"https://secwatch.observer/filing/0001193125-21-357968.md","text":"https://secwatch.observer/filing/0001193125-21-357968.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1048477/000119312521357968/0001193125-21-357968-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1048477/000119312521357968/d265991d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T00:45:51.260529+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"28d068e74b","claim":"Mark J. Alles was appointed as Director at BIOMARIN PHARMACEUTICAL INC.","evidence_excerpt":"appointed Mark J. Alles to the Board and to the Audit Committee of the Board, to be effective January 1, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1048477/000119312521357968/0001193125-21-357968-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}